Document:

Exhibit
B

 

NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT
OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO,
THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY MAY
BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION
THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH
SECURITIES.

 

Original
Issue Date:_________ , 2018

 

$
___________

 

12%
CONVERTIBLE NOTE DUE ______________, 201__1

 

THIS
12% CONVERTIBLE NOTE is one of a series of duly authorized and validly issued 12% Convertible Notes of Medovex Corp., a Nevada
corporation (the “Company”), having its principal place of business at 3060 Royal Boulevard S., Suite 150,
Alpharetta, Georgia 30022, designated as its 12% Convertible Note due ________________, 201__2 (this Note, the “Note”
and, collectively with the other Notes of such series, the “Notes”).

 

FOR
VALUE RECEIVED, the Company promises to pay to ___________________ or its registered assigns (the “Holder”),
or shall have paid pursuant to the terms hereunder, the principal sum of $____________ on the first (1st) anniversary
of the Original Issue Date (the “Maturity Date”) or such earlier date as this Note is required or permitted
to be repaid as provided hereunder, and to pay interest to the Holder on the aggregate unconverted and then outstanding principal
amount of this Note in accordance with the provisions hereof. This Note is subject to the following additional provisions:

 

Section
1. Definitions. For the purposes hereof, in addition to the terms defined elsewhere in this Note, (a) capitalized terms
not otherwise defined herein shall have the meanings ascribed to such terms in the Purchase Agreement, and (b) the following terms
shall have the following meanings:

 

“Alternate
Consideration” shall have the meaning set forth in Section 5(b).

 

 

1
One year from the Original Issue Date

2
One year from the Original Issue Date

 

    	 	1	 

     

    

 

“Bankruptcy
Event” means any of the following events: (a) the Company or any Significant Subsidiary (as such term is defined in
Rule 1-02(w) of Regulation S-X) thereof commences a case or other proceeding under any bankruptcy, reorganization, arrangement,
adjustment of debt, relief of debtors, dissolution, insolvency or liquidation or similar law of any jurisdiction relating to the
Company or any Significant Subsidiary thereof, (b) there is commenced against the Company or any Significant Subsidiary thereof
any such case or proceeding that is not dismissed within 60 days after commencement, (c) the Company or any Significant Subsidiary
thereof is adjudicated insolvent or bankrupt or any order of relief or other order approving any such case or proceeding is entered,
(d) the Company or any Significant Subsidiary thereof suffers any appointment of any custodian or the like for it or any substantial
part of its property that is not discharged or stayed within 60 calendar days after such appointment, (e) the Company or any Significant
Subsidiary thereof makes a general assignment for the benefit of creditors, (f) the Company or any Significant Subsidiary thereof
calls a meeting of its creditors with a view to arranging a composition, adjustment or restructuring of its debts, (g) the Company
or any Significant Subsidiary thereof admits in writing that it is generally unable to pay its debts as they become due, or (h)
the Company or any Significant Subsidiary thereof, by any act or failure to act, expressly indicates its consent to, approval
of or acquiescence in any of the foregoing or takes any corporate or other action for the purpose of effecting any of the foregoing.

 

“Beneficial
Ownership Limitation” shall have the meaning set forth in Section 4(c).

 

“Buy-In”
shall have the meaning set forth in Section 4(d)(v).

 

“Change
of Control Transaction” means the occurrence after the date hereof of any of (a) an acquisition after the date hereof
by an individual or legal entity or “group” (as described in Rule 13d-5(b)(1) promulgated under the Exchange Act)
of effective control (whether through legal or beneficial ownership of capital stock of the Company, by contract or otherwise)
of in excess of 50% of the voting securities of the Company (other than by means of conversion or exercise of the Notes and the
Securities issued together with the Notes), (b) the Company merges into or consolidates with any other Person, or any Person merges
into or consolidates with the Company and, after giving effect to such transaction, the stockholders of the Company immediately
prior to such transaction own less than 50% of the aggregate voting power of the Company or the successor entity of such transaction,
(c) the Company sells or transfers all or substantially all of its assets to another Person and the stockholders of the Company
immediately prior to such transaction own less than 50% of the aggregate voting power of the acquiring entity immediately after
the transaction, (d) a replacement at one time or within a three year period of more than one-half of the members of the Board
of Directors which is not approved by a majority of those individuals who are members of the Board of Directors on the date hereof
(or by those individuals who are serving as members of the Board of Directors on any date whose nomination to the Board of Directors
was approved by a majority of the members of the Board of Directors who are members on the date hereof), or (e) the execution
by the Company of an agreement to which the Company is a party or by which it is bound, providing for any of the events set forth
in clauses (a) through (d) above. The RMS Transaction shall not be deemed a Change of Control Transaction.

 

“Conversion”
shall have the meaning ascribed to such term in Section 4.

 

“Conversion
Date” shall have the meaning set forth in Section 4(a).

 

    	 	2	 

     

    

 

“Conversion
Price” shall have the meaning set forth in Section 4(b).

 

“Conversion
Schedule” means the Conversion Schedule in the form of Schedule 1 attached hereto.

 

“Conversion
Shares” means the shares of Common Stock of the Company, as applicable, issuable upon conversion of this Note in accordance
with the terms hereof.

 

“Event
of Default” shall have the meaning set forth in Section 7(a).

 

“Fundamental
Transaction” shall have the meaning set forth in Section 5(b).

 

“Interest
Rate” shall mean twelve percent (12%) per annum.

 

“Late
Fees” shall have the meaning set forth in Section 2(c).

 

“New
York Courts” shall have the meaning set forth in Section 8(d).

 

“Note
Register” shall have the meaning set forth in Section 2(b).

 

“Notice
of Conversion” shall have the meaning set forth in Section 4(a).

 

“Original
Issue Date” means the date of the first issuance of the Notes, regardless of any transfers of any Note and regardless
of the number of instruments which may be issued to evidence such Notes.

 

“Purchase
Agreement” means the Securities Purchase Agreement, dated as of _____________, 2018, among the Company and the Purchasers
party thereto (including the Holder), as amended, modified or supplemented from time to time in accordance with its terms.

 

“Share
Delivery Date” shall have the meaning set forth in Section 4(d)(ii).

 

Section
2. Interest.

 

a)
Payment of Interest. The Company shall pay interest accrued on this Note at the Interest Rate on the Maturity Date, in
cash.

 

b)
Interest Calculations. Interest on the principal balance of this Note shall be calculated on the basis of a 360-day year,
consisting of twelve 30 calendar day periods, and shall accrue daily commencing on the Original Issue Date until payment in full
of the outstanding principal, together with all accrued and unpaid interest, liquidated damages and other amounts which may become
due hereunder, has been made. Interest shall cease to accrue with respect to any principal amount converted, provided that, the
Company actually delivers the Conversion Shares within the time period required by Section 4(d)(ii) herein. Interest hereunder
will be paid to the Person in whose name this Note is registered on the records of the Company regarding registration and transfers
of this Note (the “Note Register”).

 

    	 	3	 

     

    

 

c)
Late Fee. All overdue accrued and unpaid interest to be paid hereunder shall entail a late fee at an interest rate equal
to the lesser of 18% per annum or the maximum rate permitted by applicable law (the “Late Fees”) which shall accrue
daily from the date such interest is due hereunder through and including the date of actual payment in full.

 

d)
Prepayment. Except as otherwise set forth in this Note, the Company may not prepay any portion of the principal amount
of this Note without the prior written consent of the Holder.

 

Section
3. Registration of Transfers and Exchanges.

 

a)
Different Denominations. This Note is exchangeable for an equal aggregate principal amount of Notes of different authorized
denominations, as requested by the Holder surrendering the same. No service charge will be payable for such registration of transfer
or exchange.

 

b)
Investment Representations. This Note has been issued subject to certain investment representations of the original Holder
set forth in the Purchase Agreement and may be transferred or exchanged only in compliance with the Purchase Agreement and applicable
federal and state securities laws and regulations.

 

c)
Reliance on Note Register. Prior to due presentment for transfer to the Company of this Note, the Company and any agent
of the Company may treat the Person in whose name this Note is duly registered on the Note Register as the owner hereof for the
purpose of receiving payment as herein provided and for all other purposes, whether or not this Note is overdue, and neither the
Company nor any such agent shall be affected by notice to the contrary.

 

Section
4. Conversion.

 

a)
Voluntary Conversion. At any time from and after the date that Stockholder Approval is obtained until this Note is no longer
outstanding, this Note shall be convertible, in whole or in part, into shares of Common Stock at the option of the Holder, at
any time and from time to time (subject to the conversion limitations set forth in Section 4(c) hereof). The Holder shall effect
conversions by delivering to the Company a Notice of Conversion, the form of which is attached hereto as Annex A (each,
a “Notice of Conversion”), specifying therein the principal amount of this Note and the unpaid accrued interest
hereon to be converted and the date on which such conversion shall be effected (such date, the “Conversion Date”).
If no Conversion Date is specified in a Notice of Conversion, the Conversion Date shall be the date that such Notice of Conversion
is deemed delivered hereunder. No ink-original Notice of Conversion shall be required, nor shall any medallion guarantee (or other
type of guarantee or notarization) of any Notice of Conversion from be required. To effect conversions hereunder, the Holder shall
not be required to physically surrender this Note to the Company unless the entire principal amount of this Note and all unpaid
accrued interest hereon has been so converted in which case the Holder shall surrender this Note as promptly as is reasonably
practicable after such conversion without delaying the Company’s obligation to deliver the shares on the Share Delivery
Date. Conversions hereunder shall have the effect of reducing (or eliminating, as the case may be) the unpaid accrued interest
hereon, and then next the outstanding principal amount of this Note in an amount equal to the applicable conversion. The Holder
and the Company shall maintain records showing the principal and unpaid accrued interest amount(s) converted and the date of such
conversion(s). The Company may deliver an objection to any Notice of Conversion within one (1) Business Day of delivery of such
Notice of Conversion. In the event of any dispute or discrepancy, the records of the Company shall be controlling and determinative
in the absence of manifest error. The Holder, and any assignee by acceptance of this Note, acknowledge and agree that, by reason
of the provisions of this paragraph, following conversion of a portion of this Note, the unpaid and unconverted principal amount
of this Note may be less than the amount stated on the face hereof.

 

    	 	4	 

     

    

 

b)
Conversion Price. The conversion price in effect on any Conversion Date shall be $0.40, subject to adjustment herein (the
“Conversion Price”).

 

c)
Holder’s Exercise Limitations. The Company shall not effect any conversion of this Note, and a Holder shall not have
the right to convert any portion of this Note, pursuant to this Section 4 or otherwise, to the extent that after giving effect
to such issuance after exercise as set forth on the applicable Notice of Conversion, the Holder (together with the Holder’s
Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder’s Affiliates (such Persons,
“Attribution Parties”)), would beneficially own in excess of the Beneficial Ownership Limitation. For purposes
of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution
Parties shall include the number of shares of Common Stock issuable upon conversion of this Note with respect to which such determination
is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining,
nonexercised portion of this Note beneficially owned by the Holder or any of its Affiliates or Attribution Parties, and (ii) exercise
or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation,
any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein
beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence,
for purposes of this Section 4(c), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act
and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing
to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible
for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 4(c)
applies, the determination of whether this Note is convertible (in relation to other securities owned by the Holder together with
any Affiliates and Attribution Parties) and of which portion of this Note is exercisable shall be in the sole discretion of the
Holder, and the submission of a Notice of Conversion shall be deemed to be the Holder’s determination of whether this Note
is convertible (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and
of which portion of this Note is convertible, in each case subject to the Beneficial Ownership Limitation, and the Company shall
have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 4(c), in determining the number of outstanding shares of Common Stock, the Holder may
rely on the number of outstanding shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual
report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company, or (C) a more recent
written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written
or oral request of a Holder, the Company shall within two Trading Days confirm orally and in writing to the Holder the number
of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined
after giving effect to the conversion or exercise of securities of the Company, including this Note, by the Holder or its Affiliates
or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The “Beneficial
Ownership Limitation” shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving
effect to the issuance of shares of Common Stock issuable upon exercise of this Note. The Holder, upon notice to the Company,
may increase or decrease the Beneficial Ownership Limitation provisions of this Section 4(c), provided that the Beneficial Ownership
Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to
the issuance of shares of Common Stock upon conversion of this Note held by the Holder and the provisions of this Section 4(c)
shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61st day
after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner
otherwise than in strict conformity with the terms of this Section 4(c) to correct this paragraph (or any portion hereof) which
may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements
necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to
a successor holder of this Note.

 

d)
                                         Mechanics of Conversion.

 

i.
Conversion Shares Issuable Upon Conversion of Principal and Interest Amount. The number of Conversion Shares issuable upon
a conversion hereunder shall be determined by the quotient obtained by dividing (x) the outstanding principal amount and unpaid
accrued interest to be converted by (y) the Conversion Price.

 

    	 	5	 

     

    

 

ii.
Delivery of Certificate Upon Conversion. Not later than five (5) Trading Days after each Conversion Date (the “Share
Delivery Date”), the Company shall deliver, or cause to be delivered, to the Holder a certificate or certificates representing
the Conversion Shares which, when eligible for resale under Rule 144 promulgated under the Securities Act (“Rule 144”),
shall be free of restrictive legends and trading restrictions (other than those which may then be required by the Purchase Agreement)
representing the number of Conversion Shares being acquired upon the conversion of this Note. When eligible for resale under Rule
144, the Company shall use its best efforts to deliver any certificate or certificates required to be delivered by the Company
under this Section 4(d) electronically through the Depository Trust Company or another established clearing corporation performing
similar functions.

 

iii.
Failure to Deliver Certificates. If in the case of any Notice of Conversion such certificate or certificates are not delivered
to or as directed by the applicable Holder by the seventh (7th) Trading Day after the Conversion Date, the Holder shall
be entitled to elect by written notice to the Company at any time on or before its receipt of such certificate or certificates,
to rescind such Conversion, in which event the Company shall promptly return to the Holder any original Note delivered to the
Company and the Holder shall promptly return to the Company the Common Stock certificates representing the portion of this Note
unsuccessfully tendered for conversion to the Company.

 

iv.
Obligation Absolute; Partial Liquidated Damages. The Company’s obligations to issue and deliver the Conversion Shares
upon conversion of this Note in accordance with the terms hereof are absolute and unconditional, irrespective of any action or
inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment
against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any
breach or alleged breach by the Holder or any other Person of any obligation to the Company or any violation or alleged violation
of law by the Holder or any other Person, and irrespective of any other circumstance which might otherwise limit such obligation
of the Company to the Holder in connection with the issuance of such Conversion Shares; provided, however, that
such delivery shall not operate as a waiver by the Company of any such action the Company may have against the Holder. In the
event the Holder of this Note shall elect to convert any or all of the outstanding principal amount and hereof and unpaid accrued
interest hereon, the Company may not refuse conversion based on any claim that the Holder or anyone associated or affiliated with
the Holder has been engaged in any violation of law, agreement or for any other reason, unless an injunction from a court, on
notice to Holder, restraining and or enjoining conversion of all or part of this Note shall have been sought and obtained, and
the Company posts a surety bond for the benefit of the Holder in the amount of 130% of the outstanding principal amount of this
Note, which is subject to the injunction, which bond shall remain in effect until the completion of arbitration/litigation of
the underlying dispute and the proceeds of which shall be payable to the Holder to the extent it obtains judgment. In the absence
of such injunction, the Company shall issue Conversion Shares or, if applicable, cash, upon a properly noticed conversion. If
the Company fails for any reason to deliver to the Holder such certificate or certificates pursuant to Section 4(d)(ii) by the
seventh (7th) Trading Day after the Conversion Date, the Company shall pay to the Holder, in cash, as liquidated damages
and not as a penalty, for each $1,000 of principal amount being converted, $10 per Trading Day (increasing to $20 per Trading
Day on the ninth (9th) Trading Day after such liquidated damages begin to accrue) for each Trading Day after such seventh
(7th) Trading Day until such certificates are delivered. Nothing herein shall limit a Holder’s right to pursue
actual damages or declare an Event of Default pursuant to Section 7 hereof for the Company’s failure to deliver Conversion
Shares within the period specified herein and the Holder shall have the right to pursue all remedies available to it hereunder,
at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief. The exercise of
any such rights shall not prohibit the Holder from seeking to enforce damages pursuant to any other Section hereof or under applicable
law.

 

    	 	6	 

     

    

 

v.
Compensation for Buy-In on Failure to Timely Deliver Certificates Upon Conversion. In addition to any other rights available
to the Holder, if the Company fails for any reason to deliver to the Holder such certificate or certificates by the Share Delivery
Date pursuant to Section 4(d)(ii), and if after such Share Delivery Date the Holder is required by its brokerage firm to purchase
(in an open market transaction or otherwise), or the Holder’s brokerage firm otherwise purchases, shares of Common Stock
to deliver in satisfaction of a sale by the Holder of the Conversion Shares which the Holder was entitled to receive upon the
conversion relating to such Share Delivery Date (a “Buy-In”), then the Company shall (A) pay in cash to the
Holder (in addition to any other remedies available to or elected by the Holder), if any, the amount by which (x) the Holder’s
total purchase price (including any brokerage commissions) for the Common Stock so purchased exceeds (y) the product of (1) the
aggregate number of shares of Common Stock that the Holder was entitled to receive from the conversion at issue multiplied by
(2) the actual sale price at which the sell order giving rise to such purchase obligation was executed (including any brokerage
commissions) and (B) at the option of the Holder, either reissue (if surrendered) this Note in a principal amount equal to the
principal amount of the attempted conversion (in which case such conversion shall be deemed rescinded) or deliver to the Holder
the number of shares of Common Stock that would have been issued if the Company had timely complied with its delivery requirements
under Section 4(d)(ii). For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a
Buy-In with respect to an attempted conversion of this Note with respect to which the actual sale price of the Conversion Shares
(including any brokerage commissions) giving rise to such purchase obligation was a total of $10,000 under clause (A) of the immediately
preceding sentence, the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice
indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount
of such loss. Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law
or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s
failure to timely deliver certificates representing shares of Common Stock upon conversion of this Note as required pursuant to
the terms hereof.

 

    	 	7	 

     

    

 

vi.
Reservation of Shares Issuable Upon Conversion. The Company covenants that it will at all times from and after the date
that Stockholder Approval is obtained reserve and keep available out of its authorized and unissued shares of Common Stock for
the sole purpose of issuance upon conversion of this Note, as herein provided, free from preemptive rights or any other actual
contingent purchase rights of Persons other than the Holder (and the other holders of the Notes), not less than such aggregate
number of shares of the Common Stock as shall (subject to the terms and conditions set forth in the Purchase Agreement) be issuable
(taking into account the adjustments and restrictions of Section 5) upon the conversion of the outstanding principal amount of
this Note and payment of interest hereunder. The Company covenants that all shares of Common Stock that shall be so issuable shall,
upon issue, be duly authorized, validly issued, fully paid and nonassessable.

 

vii.
Fractional Shares. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of
this Note. As to any fraction of a share which Holder would otherwise be entitled to purchase upon such conversion, the Company
shall at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Conversion Price or round up to the next whole share.

 

viii.
Transfer Taxes and Expenses. The issuance of certificates for shares of the Common Stock on conversion of this Note shall
be made without charge to the Holder hereof for any documentary stamp or similar taxes that may be payable in respect of the issue
or delivery of such certificates, provided that, the Company shall not be required to pay any tax that may be payable in respect
of any transfer involved in the issuance and delivery of any such certificate upon conversion in a name other than that of the
Holder of this Note so converted and the Company shall not be required to issue or deliver such certificates unless or until the
person or persons requesting the issuance thereof shall have paid to the Company the amount of such tax or shall have established
to the satisfaction of the Company that such tax has been paid. The Company shall pay all Transfer Agent fees required for same-day
processing of any Notice of Conversion and all fees to the Depository Trust Company (or another established clearing corporation
performing similar functions) required for same-day electronic delivery of the Conversion Shares.

 

Section
5. Certain Adjustments.

 

a)
Stock Dividends and Stock Splits. If the Company, at any time while this Note is outstanding: (i) pays a stock dividend
or otherwise makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock or any Common Stock
Equivalents (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon conversion
of, or payment of interest on, the Notes), (ii) subdivides outstanding shares of Common Stock into a larger number of shares,
(iii) combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller number of shares,
or (iv) issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock of the Company,
then in each such case the Conversion Price in effect immediately prior thereto shall be adjusted so that the Conversion Price
shall thereafter equal the price determined by multiplying the Conversion Price in effect immediately prior to such event by a
fraction of which (A) the numerator shall be the number of shares of Common Stock (excluding any treasury shares of the Company)
outstanding immediately before such event, and (B) the denominator shall be the number of shares of Common Stock outstanding immediately
after such event. Any adjustment made pursuant to this Section shall become effective immediately after the record date for the
determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.

 

    	 	8	 

     

    

 

b)
Fundamental Transaction. If, at any time while this Note is outstanding, (i) the Company, directly or indirectly, in one
or more related transactions, effects any merger or consolidation of the Company with or into another Person, (ii) the Company,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell,
tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of
the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification,
reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is
effectively converted into or exchanged for other securities, cash or property, (v) the Company, directly or indirectly, in one
or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person
acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person
or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share
purchase agreement or other business combination) (each a “Fundamental Transaction”), then, upon any subsequent
conversion of this Note, the Holder shall have the right to receive, for each Conversion Share that would have been issuable upon
such conversion immediately prior to the occurrence of such Fundamental Transaction (without regard to any limitation in Section
4(d) on the conversion of this Note), the number of shares of Common Stock of the successor or acquiring corporation or of the
Company, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Note
is convertible immediately prior to such Fundamental Transaction (without regard to any limitation in Section 4(d) on the conversion
of this Note). For purposes of any such conversion, the determination of the Conversion Price shall be appropriately adjusted
to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one (1) share of
Common Stock in such Fundamental Transaction, and the Company shall apportion the Conversion Price among the Alternate Consideration
in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of
Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the
Holder shall be given the same choice as to the Alternate Consideration it receives upon any conversion of this Note following
such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is
not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company under
this Note and the other Transaction Documents in accordance with the provisions of this Section pursuant to written agreements
in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such
Fundamental Transaction and shall, at the option of the holder of this Note, deliver to the Holder in exchange for this Note a
security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Note which
is convertible for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent
to the shares of Common Stock acquirable and receivable upon conversion of this Note (without regard to any limitations on the
conversion of this Note) prior to such Fundamental Transaction, and with a conversion price which applies the conversion price
hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to
such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such conversion
price being for the purpose of protecting the economic value of this Note immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental
Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental
Transaction, the provisions of this Note and the other Transaction Documents referring to the “Company” shall refer
instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations
of the Company under this Note and the other Transaction Documents with the same effect as if such Successor Entity had been named
as the Company herein. Notwithstanding the foregoing, the RMS Transaction shall not be deemed a Fundamental Transaction.

 

    	 	9	 

     

    

 

c)
Calculations. All calculations under this Section 5 shall be made to the nearest cent or the nearest 1/100th of a share,
as the case may be. For purposes of this Section 5, the number of shares of Common Stock deemed to be issued and outstanding as
of a given date shall be the sum of the number of shares of Common Stock (excluding any treasury shares of the Company) issued
and outstanding.

 

d)
Notice to the Holder.

 

i.
Adjustment to Conversion Price. Whenever the Conversion Price is adjusted pursuant to any provision of this Section 5,
the Company shall promptly deliver to each Holder a notice setting forth the Conversion Price after such adjustment and setting
forth a brief statement of the facts requiring such adjustment.

 

ii.
Notice to Allow Conversion by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever
form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common
Stock, (C) the Company shall authorize the granting to all holders of the Common Stock of rights or warrants to subscribe for
or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall
be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a
party, any sale or transfer of all or substantially all of the assets of the Company, of any compulsory share exchange whereby
the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary
dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be filed
at each office or agency maintained for the purpose of conversion of this Note, and shall cause to be delivered to the Holder
at its last address as it shall appear upon the Note Register, at least twenty (20) calendar days prior to the applicable record
or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such
dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of
the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined,
or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become
effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange
their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation,
merger, sale, transfer or share exchange, provided that the failure to deliver such notice or any defect therein or in the delivery
thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any
notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall
remain entitled to convert this Note during the 20-day period commencing on the date of such notice through the effective date
of the event triggering such notice except as may otherwise be expressly set forth herein.

 

    	 	10	 

     

    

 

Section
6. Automatic Conversion. Notwithstanding anything herein to the contrary, on the first Trading Day after the last to
occur of (a) the consummation of the RMS Transaction, and (b) the date that Stockholder Approval is obtained, the aggregate principal
amount of this Note and all unpaid accrued interest hereon shall automatically be converted into such number of shares of Common
Stock as determined in accordance with Section 4(d)(i) above. Upon the occurrence of such automatic conversion of this Note, the
Holder shall surrender this Note at the office of the Company. Thereupon, there shall be issued and delivered to the Holder promptly
at such office and in its name as shown on such surrendered Note, a certificate or certificates for the number of shares of Common
Stock into which this Note surrendered were convertible on the date on which such automatic conversion occurred. On the date such
automatic conversion takes place, this Note shall be converted automatically without any further action by the Holder and whether
or not this Note is surrendered to the Company; provided, however, that the Company shall not be obligated to issue certificates
evidencing the shares of Common Stock issuable upon such automatic conversion unless either this Note is delivered to the Company,
or the Holder notifies the Company that this Note have been lost, stolen or destroyed and executes an agreement satisfactory to
the Company to indemnify the Company from any loss incurred by it in connection with such lost Note. On the date of such automatic
conversion, the Holder shall be deemed to be the holder of record of the Common Stock issuable upon such conversion, notwithstanding
that this Note shall not have been surrendered at the office of the Company or that the certificates evidencing such shares of
Common Stock shall not then be actually delivered to this Holder.

 

Section
7. Events of Default.

 

a)
“Event of Default” means, wherever used herein, any of the following events (whatever the reason for such event
and whether such event shall be voluntary or involuntary or effected by operation of law or pursuant to any judgment, decree or
order of any court, or any order, rule or regulation of any administrative or governmental body):

 

i.
any default in the payment of (A) the principal amount of any Note, or (B) interest, liquidated damages and other amounts owing
to a Holder on any Note, as and when the same shall become due and payable (whether on a Conversion Date or the Maturity Date
or by acceleration or otherwise) which default, solely in the case of an interest payment or other default under clause (B) above,
is not cured within five (5) Trading Days;

 

ii.
the Company shall fail to observe or perform any other covenant or agreement contained in the Notes which failure is not cured,
if possible to cure, within seven (7) Trading Days after notice of such failure sent by the Holder or by any other Holder to the
Company;

 

iii.
a default or Event of Default (subject to any grace or cure period provided in the applicable agreement, document or instrument)
shall occur under (A) any of the Transaction Documents, or (B) any other material agreement, lease, document or instrument to
which the Company or any Subsidiary is obligated (and not covered by clause (vi) below);

 

iv.
any representation or warranty made in this Note, any other Transaction Documents, any written statement pursuant hereto or thereto
or any other report, financial statement or certificate made or delivered to the Holder or any other Holder shall be untrue or
incorrect in any material respect as of the date when made or deemed made;

 

v.
the Company or any Significant Subsidiary (as such term is defined in Rule 1-02(w) of Regulation S-X) shall be subject to a Bankruptcy
Event;

 

    	 	11	 

     

    

 

vi.
the Company or any Subsidiary shall default on any of its obligations under any mortgage, credit agreement or other facility,
indenture agreement, factoring agreement or other instrument under which there may be issued, or by which there may be secured
or evidenced, any indebtedness for borrowed money or money due under any long term leasing or factoring arrangement that (A) involves
an obligation greater than $250,000, whether such indebtedness now exists or shall hereafter be created, and (B) results in such
indebtedness becoming or being declared due and payable prior to the date on which it would otherwise become due and payable;

 

vii.
the Common Stock shall not be eligible for listing or quotation for trading on a Trading Market and shall not be eligible to resume
listing or quotation for trading thereon within seven (7) Trading Days;

 

viii.
the Company shall be a party to any Change of Control Transaction or Fundamental Transaction or shall agree to sell or dispose
of all or in excess of 40% of its assets in one transaction or a series of related transactions (whether or not such sale would
constitute a Change of Control Transaction);

 

ix.
the Company shall provide at any time notice to the Holder, including by way of public announcement, of the Company’s intention
to not honor requests for conversions of any Notes in accordance with the terms hereof; or

 

x.
any monetary judgment, writ or similar final process shall be entered or filed against the Company, any subsidiary or any of their
respective property or other assets for more than $250,000, and such judgment, writ or similar final process shall remain unvacated,
unbonded or unstayed for a period of 45 calendar days.

 

b)
Remedies Upon Event of Default. If any Event of Default occurs, the outstanding principal amount of this Note, plus accrued
but unpaid interest, liquidated damages and other amounts owing in respect thereof through the date of acceleration, shall become,
at the Holder’s election, immediately due and payable in full. Commencing five (5) days after the occurrence of any Event
of Default that results in the eventual acceleration of this Note, the interest rate on this Note shall accrue at an interest
rate equal to the lesser of 18% per annum or the maximum rate permitted under applicable law. Upon the payment in full of this
Note, the Holder shall promptly surrender this Note to or as directed by the Company. In connection with such acceleration described
herein, the Holder need not provide, and the Company hereby waives, any presentment, demand, protest or other notice of any kind,
and the Holder may immediately and without expiration of any grace period enforce any and all of its rights and remedies hereunder
and all other remedies available to it under applicable law. Such acceleration may be rescinded and annulled by the Holder at
any time prior to payment hereunder and the Holder shall have all rights as a holder of this Note until such time, if any, as
the Holder receives full payment pursuant to this Section 7(b). No such rescission or annulment shall affect any subsequent Event
of Default or impair any right consequent thereon.

 

    	 	12	 

     

    

 

Section
8. Miscellaneous.

 

a)
Notices. Any and all notices or other communications or deliveries to be provided by the Holder hereunder, including, without
limitation, any Notice of Conversion, shall be in writing and delivered personally, by facsimile, by email attachment, or sent
by a nationally recognized overnight courier service, addressed to the Company, at the address set forth above, or such other
facsimile number, email address, or address as the Company may specify for such purposes by notice to the Holder delivered in
accordance with this Section 8(a). Any and all notices or other communications or deliveries to be provided by the Company hereunder
shall be in writing and delivered personally, by facsimile, by email attachment, or sent by a nationally recognized overnight
courier service addressed to the Holder at the facsimile number or email address or address of the Holder appearing on the books
of the Company, or if no such facsimile number or email attachment or address appears on the books of the Company, at the principal
place of business of such Holder, as set forth in the Purchase Agreement. Any notice or other communication or deliveries hereunder
shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication is delivered
via facsimile at the facsimile number or email attachment to the email address set forth on the signature pages attached hereto
prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the date of transmission, if such notice
or communication is delivered via facsimile at the facsimile number or email attachment to the email address set forth on the
signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading
Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service,
or (iv) upon actual receipt by the party to whom such notice is required to be given.

 

b)
Absolute Obligation. Except as expressly provided herein, no provision of this Note shall alter or impair the obligation
of the Company, which is absolute and unconditional, to pay the principal of, liquidated damages and accrued interest, as applicable,
on this Note at the time, place, and rate, and in the coin or currency, herein prescribed. This Note is a direct debt obligation
of the Company. This Note ranks pari passu with all other Notes now or hereafter issued under the terms set forth
herein.

 

c)
Lost or Mutilated Note. If this Note shall be mutilated, lost, stolen or destroyed, the Company shall execute and deliver,
in exchange and substitution for and upon cancellation of a mutilated Note, or in lieu of or in substitution for a lost, stolen
or destroyed Note, a new Note for the principal amount of this Note so mutilated, lost, stolen or destroyed, but only upon receipt
of evidence of such loss, theft or destruction of such Note, and of the ownership hereof, reasonably satisfactory to the Company.

 

    	 	13	 

     

    

 

d)
Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Note shall be
governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles
of conflict of laws thereof. Each party agrees that all legal proceedings concerning the interpretation, enforcement and defense
of the transactions contemplated by any of the Transaction Documents (whether brought against a party hereto or its respective
Affiliates, directors, officers, shareholders, employees or agents) shall be commenced in the state and federal courts sitting
in the City of New York, Borough of Manhattan (the “New York Courts”). Each party hereto hereby irrevocably
submits to the exclusive jurisdiction of the New York Courts for the adjudication of any dispute hereunder or in connection herewith
or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction
Documents), and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not
personally subject to the jurisdiction of such New York Courts, or such New York Courts are improper or inconvenient venue for
such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence
of delivery) to such party at the address in effect for notices to it under this Note and agrees that such service shall constitute
good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right
to serve process in any other manner permitted by applicable law. Each party hereto hereby irrevocably waives, to the fullest
extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this
Note or the transactions contemplated hereby. If either party shall commence an action or proceeding to enforce any provisions
of this Note, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorney’s
fees and other costs and expenses incurred in the investigation, preparation and prosecution of such action or proceeding.

 

e)
Waiver. Any waiver by the Company or the Holder of a breach of any provision of this Note shall not operate as or be construed
to be a waiver of any other breach of such provision or of any breach of any other provision of this Note. The failure of the
Company or the Holder to insist upon strict adherence to any term of this Note on one or more occasions shall not be considered
a waiver or deprive that party of the right thereafter to insist upon strict adherence to that term or any other term of this
Note. Any waiver by the Company or the Holder must be in writing.

 

f)
Severability. If any provision of this Note is invalid, illegal or unenforceable, the balance of this Note shall remain
in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain applicable to all
other Persons and circumstances. If it shall be found that any interest or other amount deemed interest due hereunder violates
the applicable law governing usury, the applicable rate of interest due hereunder shall automatically be lowered to equal the
maximum rate of interest permitted under applicable law. The Company covenants (to the extent that it may lawfully do so) that
it shall not at any time insist upon, plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay,
extension or usury law or other law which would prohibit or forgive the Company from paying all or any portion of the principal
of or interest on this Note as contemplated herein, wherever enacted, now or at any time hereafter in force, or which may affect
the covenants or the performance of this indenture, and the Company (to the extent it may lawfully do so) hereby expressly waives
all benefits or advantage of any such law, and covenants that it will not, by resort to any such law, hinder, delay or impede
the execution of any power herein granted to the Holder, but will suffer and permit the execution of every such as though no such
law has been enacted.

 

    	 	14	 

     

    

 

g)
Next Business Day. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day,
such payment shall be made on the next succeeding Business Day.

 

h)
Headings. The headings contained herein are for convenience only, do not constitute a part of this Note and shall not be
deemed to limit or affect any of the provisions hereof.

 

i)
Remedies, Characterizations, Other Obligations, Breaches and Injunctive Relief. The remedies provided in this Note shall
be cumulative and in addition to all other remedies available under this Note and any of the other Transaction Documents at law
or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit the Holder’s
right to pursue actual damages for any failure by the Company to comply with the terms of this Note. The Company covenants to
the Holder that there shall be no characterization concerning this instrument other than as expressly provided herein. Amounts
set forth or provided for herein with respect to payments, conversion and the like (and the computation thereof) shall be the
amounts to be received by the Holder and shall not, except as expressly provided herein, be subject to any other obligation of
the Company (or the performance thereof). The Company acknowledges that a breach by it of its obligations hereunder may cause
irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate. The Company therefore agrees
that, in the event of any such breach or threatened breach, the Holder shall be entitled, in addition to all other available remedies,
to seek an injunction restraining any such breach or any such threatened breach, without the necessity of showing economic loss
and without any bond or other security being required. The Company shall provide all information and documentation to the Holder
that is requested by the Holder to enable the Holder to confirm the Company’s compliance with the terms and conditions of
this Note

 

IN
WITNESS WHEREOF, the Company has caused this Note to be duly executed by its duly authorized officer as of the date first above
indicated.

 

	 	MEDOVEX
    CORP.
	 	 
	 	By:	 
	 	Name:
    	William
    E. Horne
	 	Title:
    	Chief
    Executive Officer

 

    	 	15	 

     

    

 

ANNEX
A

NOTICE
OF CONVERSION

 

The
undersigned hereby elects to convert principal and interest under the 12% Convertible Note due ___________, 201__ of Medovex Corp.,
a Nevada corporation (the “Company”), into shares of common stock (the “Common Stock”),
of the Company according to the conditions hereof, as of the date written below. If shares of Common Stock are to be issued in
the name of a person other than the undersigned, the undersigned will pay all transfer taxes payable with respect thereto and
is delivering herewith such certificates and opinions as reasonably requested by the Company in accordance therewith. No fee will
be charged to the holder for any conversion, except for such transfer taxes, if any.

 

By
the delivery of this Notice of Conversion the undersigned represents and warrants to the Company that its ownership of the Common
Stock does not exceed the amounts specified under Section 4 of the Note, as determined in accordance with Section 13(d) of the
Exchange Act.

 

The
undersigned agrees to comply with the prospectus delivery requirements under the applicable securities laws in connection with
any transfer of the aforesaid shares of Common Stock.

 

	Conversion
    calculations:	 	 
	 	 	 
	 	Date
    to Effect Conversion: ____________________________________	 
	 	 	 
	 	Principal
    and Interest to be Converted: ___________________________	 
	 	 	 
	 	Number
    of shares of Common Stock to be issued: __________________	 
	 	 	 
	 	Signature:
    _________________________________________________	 
	 	 	 
	 	Name:
    ____________________________________________________	 
	 	Address
    for Delivery of Common Stock Certificates:	 
	 	 _________________________________________________________	 
	 	 _________________________________________________________	 
	 	 	 
	 	:
    Or	 
	 	 	 
	 	DWAC
    Instructions:	 
	 	 	 
	 	Broker
    No: ________________________________________________	 
	 	Account
    No: _______________________________________________	 

 

    	 	A-1	 

     

    

 

Schedule
1

 

CONVERSION
SCHEDULE

 

The
12% Convertible Note due ______________, 201__ in the original principal amount of $___________________ is issued by Medovex Corp.,
a Nevada corporation. This Conversion Schedule reflects conversions made under Section 4 of the above referenced Note.

 

Dated:____________________

 

	Date
    of Conversion

 (or for first entry, 

Original Issue Date)	 	Amount
    of 

Conversion	 	Aggregate
    Principal Amount Remaining Subsequent

 to Conversion 
 (or original Principal Amount)	 	Company
    Attest
	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	 	 	 	 	 

 

    	 	Schedule 1 - Page 1Exhibit
C

 

THIS
SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE
UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN
ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH
A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED
IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

THE
TRANSFER OF THIS WARRANT IS RESTRICTED AS DESCRIBED HEREIN.

 

Medovex
Corp.

 

Warrant
for the Purchase of Shares of Common Stock, par value $0.001 per Share

 

	No.
    [●]	[●]
    Shares

 

THIS
CERTIFIES that, for value received, [●], whose address is [●] (the “Holder”), is
entitled to subscribe for and purchase from Medovex Corp., a Nevada corporation (the “Company”), upon the terms
and conditions set forth herein, [●]1 shares of the Company’s Common Stock, par value $0.001 per
Share (“Common Stock”), at a price of $0.75 per share (the “Exercise Price”). As
used herein the term “this Warrant” shall mean and include this Warrant and any Common Stock or warrants hereafter
issued as a consequence of the exercise or transfer of this Warrant in whole or in part. This Warrant was issued to the Holder
in connection with the transactions contemplated by that certain Securities Purchase Agreement (the “Purchase Agreement”),
dated [●], 2018, among the Company and the Purchasers signatory thereto. Capitalized terms used in this Warrant but
not defined herein shall have the meanings ascribed to such terms in the Purchase Agreement.

 

The
number of shares of Common Stock issuable upon exercise of this Warrant (the “Warrant Shares”) and the Exercise
Price may be adjusted from time to time as hereinafter set forth.

 

 

1
Equals the number of shares of Common Stock into which the Holder’s Note is convertible as of the closing date (i.e.,
100% “warrant coverage”).

 

    	 	1	 

    	 

    

 

1.
Exercise Period. Subject to the terms and conditions set forth herein, this Warrant may be exercised at any time or from
time to time during the period commencing at 10:00 a.m. (New York City time) on the day immediately following the date that Stockholder
Approval is obtained, and ending at 5:00 p.m. (New York City time) on the third (3rd) anniversary thereof (the “Exercise
Period”).

 

2.
Procedure for Exercise; Effect of Exercise.

 

(a)
Cash Exercise. This Warrant may be exercised, in whole or in part, by the Holder during normal business hours on any business
day during the Exercise Period by (i) the presentation and surrender of this Warrant to the Company at its principal office along
with a duly executed Notice of Exercise (in the form attached hereto) specifying the number of Warrant Shares to be purchased,
and (ii) delivery of payment to the Company of the Exercise Price for the number of Warrant Shares specified in the Notice of
Exercise by cash, wire transfer of immediately available funds to a bank account specified by the Company, or by certified or
bank cashier’s check.

 

(b)
Cashless Exercise. This Warrant may also be exercised by the Holder through a cashless exercise, as described in this Section
2(b). In such case, this Warrant may be exercised, in whole or in part, by the Holder during normal business hours on any business
day during the Exercise Period by the presentation and surrender of this Warrant to the Company at its principal office along
with a duly executed Notice of Exercise specifying the number of Warrant Shares to be applied to such exercise. The number of
shares of Common Stock to be issued upon exercise of this Warrant pursuant to this Section 2(b) shall equal the value of this
Warrant (or the portion thereof being canceled) computed as of the date of delivery of this Warrant to the Company using the following
formula:

 

	 	X	=	Y(A-B)

        A

Where:

 

	 	X	=	the
    number of shares of Common Stock to be issued to Holder under this Section 2(b);
	 	Y	=	the
    number of Warrant Shares identified in the Notice of Exercise as being applied to the subject exercise;
	 	A	=	the
    Current Market Price on such date; and
	 	B	=	the
    Exercise Price on such date.

 

For
purposes of this Section 2(b), Current Market Price shall have the definition provided in Section 6(g).

 

The
Company acknowledges and agrees that this Warrant was issued on the date set forth at the end of this Warrant. Consequently, the
Company acknowledges and agrees that, if the Holder conducts a cashless exercise pursuant to this Section 2(b), the period during
which the Holder held this Warrant may, for purposes of Rule 144 promulgated under the Securities Act of 1933, as amended (the
“Securities Act”), be “tacked” to the period during which the Holder holds the Warrant Shares received
upon such cashless exercise.

 

    	 	2	 

    	 

    

 

Notwithstanding
the foregoing, the Holder may conduct a cashless exercise pursuant to this Section 2(b) only after the six (6) month anniversary
of the initial issuance date of this Warrant.

 

(c)
Effect of Exercise. Upon receipt by the Company of this Warrant and a Notice of Exercise, together with proper payment
of the Exercise Price, as provided in this Section 2, the Company agrees that such Warrant Shares shall be deemed to be issued
to the Holder as the record holder of such Warrant Shares as of the close of business on the date on which this Warrant has been
surrendered and payment has been made for such Warrant Shares in accordance with this Warrant and the Holder shall be deemed to
be the holder of record of the Warrant Shares, notwithstanding that the stock transfer books of the Company shall then be closed
or that certificates representing such Warrant Shares shall not then be actually delivered to the Holder. A stock certificate
or certificates for the Warrant Shares specified in the Notice of Exercise shall be delivered to the Holder as promptly as practicable,
and in any event within seven (7) business days, thereafter. The stock certificate(s) so delivered shall be in any such denominations
as may be reasonably specified by the Holder in the Notice of Exercise. If this Warrant should be exercised in part only, the
Company shall, upon surrender of this Warrant for cancellation, execute and deliver a new Warrant evidencing the right of the
Holder to purchase the balance of the Warrant Shares subject to purchase hereunder.

 

3.
Registration of Warrants; Transfer of Warrants. Any Warrants issued upon the transfer or exercise in part of this Warrant
shall be numbered and shall be registered in a Warrant Register as they are issued. The Company shall be entitled to treat the
registered holder of any Warrant on the Warrant Register as the owner in fact thereof for all purposes and shall not be bound
to recognize any equitable or other claim to or interest in such Warrant on the part of any other person, and shall not be liable
for any registration or transfer of Warrants which are registered or to be registered in the name of a fiduciary or the nominee
of a fiduciary unless made with the actual knowledge that a fiduciary or nominee is committing a breach of trust in requesting
such registration or transfer, or with the knowledge of such facts that its participation therein amounts to bad faith. This Warrant
shall be transferable only on the books of the Company upon delivery thereof duly endorsed by the Holder or by its duly authorized
attorney or representative, or accompanied by proper evidence of succession, assignment, or authority to transfer. In all cases
of transfer by an attorney, executor, administrator, guardian, or other legal representative, duly authenticated evidence of his
or its authority shall be produced. Upon any registration of transfer, the Company shall deliver a new Warrant or Warrants to
the person entitled thereto. This Warrant may be exchanged, at the option of the Holder thereof, for another Warrant, or other
Warrants of different denominations, of like tenor and representing in the aggregate the right to purchase a like number of Warrant
Shares, upon surrender to the Company or its duly authorized agent.

 

    	 	3	 

    	 

    

 

4.
Restrictions on Transfer. (a) The Holder, as of the date of issuance hereof, represents to the Company that such Holder
is acquiring the Warrants for its own account for investment purposes and not with a view to the distribution thereof or of the
Warrant Shares. Notwithstanding any provisions contained in this Warrant to the contrary, this Warrant and the related Warrant
Shares shall not be transferable except pursuant to the proviso contained in the following sentence or upon the conditions specified
in this Section 4, which conditions are intended, among other things, to insure compliance with the provisions of the Securities
Act and applicable state law in respect of the transfer of this Warrant or such Warrant Shares. The Holder by acceptance of this
Warrant agrees that the Holder will not transfer this Warrant or the related Warrant Shares prior to delivery to the Company of
an opinion of the Holder’s counsel (as such opinion and such counsel are described in Section 4(b) hereof) or until registration
of such Warrant Shares under the Securities Act has become effective or after a sale of such Warrant or Warrant Shares has been
consummated pursuant to Rule 144 or Rule 144A under the Securities Act; provided, however, that the Holder may freely transfer
this Warrant or such Warrant Shares (without delivery to the Company of an opinion of counsel) (i) to one of its nominees, affiliates
or a nominee thereof, (ii) to a pension or profit-sharing fund established and maintained for its employees or for the employees
of any affiliate, (iii) from a nominee to any of the aforementioned persons as beneficial owner of this Warrant or such Warrant
Shares, (iv) to a qualified institutional buyer, so long as such transfer is effected in compliance with Rule 144A under the Securities
Act, or (v) to an accredited investor (as such term is defined in Regulation D under the Securities Act).

 

(b)
The Holder, by its acceptance hereof, agrees that prior to any transfer of this Warrant or of the related Warrant Shares (other
than as permitted by Section 4(a) hereof or pursuant to a registration under the Securities Act), the Holder will give written
notice to the Company of its intention to effect such transfer, together with an opinion of such counsel for the Holder as shall
be reasonably acceptable to the Company, to the effect that the proposed transfer of this Warrant and/or such Warrant Shares may
be effected without registration under the Securities Act. Upon delivery of such notice and opinion to the Company, the Holder
shall be entitled to transfer this Warrant and/or such Warrant Shares in accordance with the intended method of disposition specified
in the notice to the Company.

 

(c)
Each stock certificate representing Warrant Shares issued upon exercise or exchange of this Warrant shall bear the following legend
unless the opinion of counsel referred to in Section 4(b) states such legend is not required:

 

“THIS
SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE
UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN
ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH
A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED
IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.”

 

    	 	4	 

    	 

    

 

The
Holder understands that the Company may place, and may instruct any transfer agent or depository for the Warrant Shares to place,
a stop transfer notation in the securities records in respect of the Warrant Shares.

 

5.
Reservation of Shares. The Company shall at all times during the Exercise Period reserve and keep available out of its
authorized and unissued Common Stock, solely for the purpose of providing for the exercise of the rights to purchase all Warrant
Shares granted pursuant to the Warrants, such number of shares of Common Stock as shall, from time to time, be sufficient therefor.
The Company covenants that all shares of Common Stock issuable upon exercise of this Warrant, upon receipt by the Company of the
full Exercise Price therefor, and all shares of Common Stock issuable upon conversion of this Warrant, shall be validly issued,
fully paid, non-assessable, and free of preemptive rights, and free from all taxes, claims, liens, charges and other encumbrances.

 

6.
Exercise Price Adjustments. The Exercise Price shall be subject to adjustment from time to time as follows:

 

(a)
(i) In the event that the Company shall (A) pay a dividend or make a distribution to all its stockholders, in shares of Common
Stock, on any class of capital stock of the Company or any subsidiary which is not directly or indirectly wholly owned by the
Company, (B) split or subdivide its outstanding Common Stock into a greater number of shares, or (C) combine its outstanding Common
Stock into a smaller number of shares, then in each such case the Exercise Price in effect immediately prior thereto shall be
adjusted so that the Holder of a Warrant thereafter surrendered for Exercise shall be entitled to receive the number of shares
of Common Stock that such Holder would have owned or have been entitled to receive after the occurrence of any of the events described
above had such Warrant been exercised immediately prior to the occurrence of such event. An adjustment made pursuant to this Section
6(a)(i) shall become effective immediately after the close of business on the record date in the case of a dividend or distribution
(except as provided in Section 6(e) below) and shall become effective immediately after the close of business on the effective
date in the case of such subdivision, split or combination, as the case may be. Any shares of Common Stock issuable in payment
of a dividend shall be deemed to have been issued immediately prior to the close of business on the record date for such dividend
for purposes of calculating the number of outstanding shares of Common Stock under clauses (ii) and (iii) below.

 

    	 	5	 

    	 

    

 

(ii)
In the event that the Company shall commit to hereafter issue or distribute Common Stock or Common Stock Equivalents (other than
in an Exempt Issuance) (“New Securities”), in any such case at a price per share less than the Current Market
Price per share on the earliest of (A) the date the Company shall enter into a firm contract for such issuance or distribution,
(B) the record date for the determination of stockholders entitled to receive any such New Securities, if applicable, or (C) the
date of actual issuance or distribution of any such New Securities (provided that the issuance of Common Stock upon the exercise
of New Securities that are rights, warrants, options or convertible or exchangeable securities (“New Derivative Securities”)
will not cause an adjustment in the Exercise Price if no such adjustment would have been required at the time such New Derivative
Security was issued), then the Exercise Price in effect immediately prior to such earliest date shall be adjusted so that the
Exercise Price shall equal the price determined by multiplying the Exercise Price in effect immediately prior to such earliest
date by the fraction:

 

(x)
whose numerator shall be (I) the number of shares of Common Stock outstanding on such date plus (II) the number of shares
of Common Stock which the aggregate offering price of the total number of New Securities so offered would have purchased at such
Current Market Price (such amount, with respect to any New Derivative Securities, determined by multiplying the total number of
shares of Common Stock subject thereto by the exercise price of such New Derivative Securities, and dividing the product so obtained
by such Current Market Price), and

 

(y)
whose denominator shall be (I) the number of shares of Common Stock outstanding on such date plus (II) the number of additional
shares of Common Stock to be issued or distributed or receivable upon exercise of any such New Derivative Security.

 

Such
adjustment shall be made successively whenever any such New Securities are issued. In determining whether any New Derivative Securities
entitle the holders to subscribe for or purchase shares of Common Stock at less than such Current Market Price, and in determining
the aggregate offering price of shares of Common Stock so issued, there shall be taken into account any consideration received
by the Company for such Common Stock or New Derivative Securities, the value of such consideration, if other than cash, to be
determined by the Board of Directors, whose determination shall be conclusive and described in a certificate filed with the records
of corporate proceedings of the Company. If any New Derivative Security to purchase or acquire Common Stock, the issuance of which
resulted in an adjustment in the Exercise Price pursuant to this subsection (ii) shall expire and shall not have been exercised,
the Exercise Price shall immediately upon such expiration be recomputed to the Exercise Price which would have been in effect
had the adjustment of the Exercise Price made upon the issuance of such New Derivative Security been made on the basis of offering
for subscription, purchase or issuance, as the case may be, only of that number of shares of Common Stock actually purchased or
issued upon the actual exercise of such New Derivative Security.

 

(iii)
No adjustment in the Exercise Price shall be required unless the adjustment would require an increase or decrease of at least
1% in the Exercise Price then in effect; provided, however, that any adjustments that by reason of this Section 6(a) are
not required to be made shall be carried forward and taken into account in any subsequent adjustment. All calculations under this
Section 6(a) shall be made to the nearest cent or nearest 1/100th of a share.

 

(iv)
The Company from time to time may reduce the Exercise Price by any amount for any period of time in the discretion of the Board
of Directors. A voluntary reduction of the Exercise Price does not change or adjust the Exercise Price otherwise in effect for
purposes of this Section 6(a).

 

    	 	6	 

    	 

    

 

(v)
In the event that, at any time as a result of an adjustment made pursuant to Sections 6(a)(i) through 6(a)(iii) above, the Holder
of any Warrant thereafter surrendered for exercise shall become entitled to receive any shares of the Company other than shares
of the Common Stock, thereafter the number of such other shares so receivable upon exercise of any such Warrant shall be subject
to adjustment from time to time in a manner and on terms as nearly equivalent as practicable to the provisions with respect to
the Common Stock contained in Sections 6(a)(i) through 6(a)(iv) above, and the other provisions of this Section 6(a) with respect
to the Common Stock shall apply on like terms to any such other shares.

 

(b)
In case of any reclassification of the Common Stock (other than in a transaction to which Section 6(a)(i) applies), any consolidation
of the Company with, or merger of the Company into, any other entity, any merger of another entity into the Company (other than
a merger that does not result in any reclassification, conversion, exchange or cancellation of outstanding shares of Common Stock
of the Company), any sale or transfer of all or substantially all of the assets of the Company or any compulsory share exchange,
pursuant to which share exchange the Common Stock is converted into other securities, cash or other property, then lawful provision
shall be made as part of the terms of such transaction whereby the Holder of a Warrant then outstanding shall have the right thereafter,
during the period such Warrant shall be exercisable, to exercise such Warrant only for the kind and amount of securities, cash
and other property receivable upon the reclassification, consolidation, merger, sale, transfer or share exchange by a holder of
the number of shares of Common Stock of the Company into which a Warrant might have been able to exercise for immediately prior
to the reclassification, consolidation, merger, sale, transfer or share exchange assuming that such holder of Common Stock failed
to exercise rights of election, if any, as to the kind or amount of securities, cash or other property receivable upon consummation
of such transaction subject to adjustment as provided in Section 6(a) above following the date of consummation of such transaction.
The provisions of this Section 6(b) shall similarly apply to successive reclassifications, consolidations, mergers, sales, transfers
or share exchanges.

 

(c)
If:

 

	 	(i)	the
    Company shall take any action which would require an adjustment in the Exercise Price pursuant to Section 6(a); or
	 	 	 
	 	(ii)
    	the
    Company shall authorize the granting to the holders of its Common Stock generally of rights, warrants or options to subscribe
    for or purchase any shares of any class or any other rights, warrants or options; or
	 	 	 
	 	(iii)	there
    shall be any reclassification or change of the Common Stock (other than a subdivision or combination of its outstanding Common
    Stock or a change in par value) or any consolidation, merger or statutory share exchange to which the Company is a party and
    for which approval of any stockholders of the Company is required, or the sale or transfer of all or substantially all of
    the assets of the Company; or

 

    	 	7	 

    	 

    

 

	 	(iv)	there
    shall be a voluntary or involuntary dissolution, liquidation or winding up of the Company;

 

then,
in each such case, the Company shall cause to be filed with the transfer agent for the Warrants and shall cause to be mailed to
each Holder at such Holder’s address as shown on the books of the transfer agent for the Warrants, as promptly as possible,
but at least 30 days prior to the applicable date hereinafter specified, a notice stating (A) the date on which a record is to
be taken for the purpose of such dividend, distribution or granting of rights, warrants or options, or, if a record is not to
be taken, the date as of which the holders of Common Stock of record to be entitled to such dividend, distribution or rights,
warrants or options are to be determined, or (B) the date on which such reclassification, change, consolidation, merger, statutory
share exchange, sale, transfer, dissolution, liquidation or winding-up is expected to become effective or occur, and the date
as of which it is expected that holders of Common Stock of record shall be entitled to exchange their shares of Common Stock for
securities or other property deliverable upon such reclassification, change, consolidation, merger, statutory share exchange,
sale, transfer, dissolution, liquidation or winding up. Failure to give such notice or any defect therein shall not affect the
legality or validity of the proceedings described in this Section 6(c).

 

(d)
Whenever the Exercise Price is adjusted as herein provided, the Company shall promptly file with the transfer agent for the Warrants
a certificate of an officer of the Company setting forth the Exercise Price after the adjustment and setting forth a brief statement
of the facts requiring such adjustment and a computation thereof. The Company shall promptly cause a notice of the adjusted Exercise
Price to be mailed to each Holder.

 

(e)
In any case in which Section 6(a) provides that an adjustment shall become effective immediately after a record date for an event
and the date fixed for such adjustment pursuant to Section 6(a) occurs after such record date but before the occurrence of such
event, the Company may defer until the actual occurrence of such event (i) issuing to the Holder of any Warrants exercised after
such record date and before the occurrence of such event the additional shares of Common Stock issuable upon such conversion by
reason of the adjustment required by such event over and above the Common Stock issuable upon such exercise before giving effect
to such adjustment, and (ii) paying to such holder any amount in cash in lieu of any fraction pursuant to Section 6(h).

 

(f)
In case the Company shall take any action affecting the Common Stock, other than actions described in this Section 6, which in
the opinion of the Board of Directors would materially adversely affect the exercise right of the Holders, the Exercise Price
may be adjusted, to the extent permitted by law, in such manner, if any, and at such time, as the Board of Directors may determine
to be equitable in the circumstances; provided, however, that in no event shall the Board of Directors be required to take
any such action.

 

    	 	8	 

    	 

    

 

(g)
For the purpose of any computation under Section 2(b) or this Section 6, the “Current Market Price” per share
of Common Stock shall mean the VWAP of the Common Stock on the day in question.

 

(h)
The Company shall not be required to issue fractions of shares of Common Stock or other capital stock of the Company upon the
exercise of this Warrant. If any fraction of a share would be issuable on the exercise of this Warrant (or specified portions
thereof), the Company shall purchase such fraction for an amount in cash equal to the same fraction of the Current Market Price
of such share of Common Stock on the date of exercise of this Warrant.

 

7.
Transfer Taxes. The issuance of any shares or other securities upon the exercise of this Warrant, and the delivery of certificates
or other instruments representing such shares or other securities, shall be made without charge to the Holder for any tax or other
charge in respect of such issuance. The Company shall not, however, be required to pay any tax which may be payable in respect
of any transfer involved in the issue and delivery of any certificate in a name other than that of the Holder and the Company
shall not be required to issue or deliver any such certificate unless and until the person or persons requesting the issue thereof
shall have paid to the Company the amount of such tax or shall have established to the satisfaction of the Company that such tax
has been paid.

 

8.
Loss or Mutilation of Warrant. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction,
or mutilation of any Warrant (and upon surrender of any Warrant if mutilated), and upon reimbursement of the Company’s reasonable
incidental expenses, the Company shall execute and deliver to the Holder thereof a new Warrant of like date, tenor, and denomination.

 

9.
No Rights as a Stockholder. The Holder of any Warrant shall not have, solely on account of such status, any rights of a
stockholder of the Company, either at law or in equity, or to any notice of meetings of stockholders or of any other proceedings
of the Company, except as provided in this Warrant.

 

10.
Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall
be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the
principles of conflicts of law thereof.

 

*
* *

 

    	 	9	 

    	 

    

 

Issuance
date: [●], 201[●]

 

	 	MEDOVEX
    CORP.
	 	 	 
	 	By:	 
	 	 	William
    E. Horne,
	 	 	Chief
    Executive Officer

 

    	 	10	 

    	 

    

 

FORM
OF ASSIGNMENT

 

(To
be executed by the registered holder if such holder desires to transfer the attached Warrant.)

 

FOR
VALUE RECEIVED,_________________________hereby sells, assigns, and transfers unto __________________ a Warrant to purchase __________ shares of Common
Stock, par value $0.001 per share, of Medovex Corp., a Nevada corporation (the “Company”), together with all
right, title, and interest therein, and does hereby irrevocably constitute and appoint________________________________________ attorney to transfer such Warrant on the
books of the Company, with full power of substitution.

 

	 	 	 
	 	Dated:	 
	 	 	 
	 	By:	 
	 	 	Signature

 

The
signature on the foregoing Assignment must correspond to the name as written upon the face of this Warrant in every particular,
without alteration or enlargement or any change whatsoever.

 

    	 	 	 

    	 

    

 

	To:	Medovex
    Corp.	 
	 	3060
    Royal Boulevard S., Suite 150	 
	 	Alpharetta,
    Georgia 30022	 
	 	Attention:
    Chief Executive Officer	 

 

NOTICE
OF EXERCISE

 

The
undersigned hereby exercises his or its rights to purchase _______ Warrant Shares covered by the within Warrant and tenders payment
herewith in the amount of $_________ by [tendering cash or delivering a certified check or bank cashier’s check, payable
to the order of the Company] [surrendering ______ shares of Common Stock received upon exercise of the attached Warrant, which
shares have a Current Market Price equal to such payment] in accordance with the terms thereof, and requests that certificates
for such securities be issued in the name of, and delivered to:

 

_______________________________________

 

_______________________________________

 

_______________________________________

 

(Print
Name, Address and Social Security

or
Tax Identification Number)

 

and,
if such number of Warrant Shares shall not be all the Warrant Shares covered by the within Warrant, that a new Warrant for the
balance of the Warrant Shares covered by the within Warrant be registered in the name of, and delivered to, the undersigned at
the address stated below.

 

	 	Dated:	
	 	 	 
	 	By:	
	 	 	Print
    Name
	 	 	 
	 	 	
	 	 	Signature

 

Address:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}]]